Description
The Anti SS-B (La) test is a highly specific blood assay primarily used in conjunction with the Anti SS-A (Ro) test to diagnose Sjögren’s syndrome and Systemic Lupus Erythematosus (SLE). It detects autoantibodies that target the SS-B (La) extractable nuclear antigen, providing critical diagnostic clarity for patients suffering from severe autoimmune-driven dryness of the eyes and mouth.
Overview:
Like Anti SS-A, the Anti SS-B (La) antibody is a type of Antinuclear Antibody (ANA) that specifically targets an Extractable Nuclear Antigen (ENA) within the body’s cells. Interestingly, Anti SS-B (La) antibodies are almost never found alone; they typically appear only in the presence of Anti SS-A (Ro) antibodies. Testing for both simultaneously provides a much clearer diagnostic picture for specific systemic autoimmune diseases.
Clinical Significance:
- Confirming Sjögren’s Syndrome: Anti SS-B (La) is found in approximately 40–50% of patients with primary Sjögren’s syndrome. When a patient tests positive for both SS-A and SS-B, it is one of the strongest serological indicators of the disease.
- Lupus (SLE) Evaluation: It is present in about 10–15% of patients with SLE. Its presence can help subclassify the disease and is often associated with a lower incidence of severe kidney involvement (lupus nephritis) compared to other lupus autoantibodies.
- Pregnancy and Neonatal Risk: Similar to SS-A, SS-B antibodies can cross the placenta during pregnancy. Evaluating their presence is an essential part of assessing the risk of neonatal lupus and congenital heart block in the developing fetus.
- Comprehensive ENA Profiling: This test is rarely ordered in isolation. It is typically part of an ENA panel following a positive general ANA screen to pinpoint the exact nature of the autoimmune response.
When is this test recommended?
Healthcare providers typically order the Anti SS-B (La) Antibody test when:
- A patient exhibits classic Sjögren’s syndrome symptoms, such as debilitating dry eyes (often feeling like sand is in them) and a severely dry mouth (difficulty swallowing dry foods).
- A patient has already tested positive for a general ANA or specifically for Anti SS-A (Ro) antibodies.
- Evaluating a patient with suspected Systemic Lupus Erythematosus (SLE).
- A pregnant woman with a known autoimmune condition requires risk assessment for neonatal complications.
Sample Requirements:
- Specimen: Blood (Serum).
- Container: A standard Gold-top Serum Separator Tube (SST).
Patient Preparation:
- General: No fasting is strictly required for this test. Patients can eat and drink normally prior to the blood draw. Patients should ensure their physician has a complete list of their current medications.
